Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laterell Venture Partners (LVP) is a venture capital firm specializing in early-stage healthcare and life sciences investments. Founded in 2001 and headquartered in the San Francisco Bay Area, the firm focuses on identifying breakthrough technologies in biotechnology, medical devices, and diagnostics. LVP typically invests in seed and Series A rounds, providing both financial capital and strategic expertise to help entrepreneurs build successful companies. The firm's investment team comprises professionals with deep experience in clinical medicine, scientific research, and financial management. Throughout its history, LVP has managed multiple funds and has been involved in several high-profile exits through acquisitions and initial public offerings. As an investment firm, LVP does not develop its own therapeutic pipeline but instead supports a diverse portfolio of healthcare startups.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laterell Venture Partners.